Metabolic Disorders: Difference between revisions
From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs) No edit summary |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 10: | Line 10: | ||
*[[HMG-CoA Reductase]] | *[[HMG-CoA Reductase]] | ||
*[[Molecular_Playground/Human_PPCA|Protective Protein/Cathepsin A (PPCA)]] | *[[Molecular_Playground/Human_PPCA|Protective Protein/Cathepsin A (PPCA)]] | ||
*[[Bacterial thiolase|Thiolase]] | *[[Bacterial thiolase|Thiolase]] | ||
*[[Treatment_of_Gaucher_disease|Treatment of Gaucher Disease]] | *[[Treatment_of_Gaucher_disease|Treatment of Gaucher Disease]] | ||
| Line 25: | Line 24: | ||
*[[: Category:Metabolic disorder|Metabolic Disorder]] | *[[: Category:Metabolic disorder|Metabolic Disorder]] | ||
<br /> | <br /> | ||
To View FDA Approved Treatments for [[Metabolic Disorders]] See: [[Pharmaceutical_Drugs#Treatments|Treatments]] | |||
To view other Proteopedia pages about diseases & drug targets, See: [[Pharmaceutical_Drug_Targets|Pharmaceutical Drug Targets]] | To view other Proteopedia pages about diseases & drug targets, See: [[Pharmaceutical_Drug_Targets|Pharmaceutical Drug Targets]] | ||
